semaglutide in chicago il Semaglutide & Tirzepatide Weight Loss

Obesity has also been linked to chronic inflammation

Even though they target the body differently, both offer reliable, medically supervised support for long-term weight management

It comes in two FDA-approved forms, both weekly injections: Mounjaro: type 2 diabetes (2.5 to 15 mg) Zepbound: obesity (2.5 to 15 mg) and moderate-to-severe obstructive sleep apnea in adults with obesity (approved December 2024) No oral tirzepatide exists as of April 2026

Trulicity is an FDA-cleared diabetes treatment (reflecting FDA approval for its indicated use), but lawsuits examine whether some patients still experienced serious health problems and severe complications that warranted closer scrutiny

At 2.4mg: approximately 2 doses